Article Details

Evoke Pharma, Inc. (NASDAQ:EVOK): Why Investors Shouldn't Ditch EVOK stock in 2021

Retrieved on: 2021-06-02 13:07:30

Tags for this article:

Click the tags to see associated articles and topics

Evoke Pharma, Inc. (NASDAQ:EVOK): Why Investors Shouldn't Ditch EVOK stock in 2021. View article details on hiswai:

Excerpt

Vanguard Group, Inc. (The) holds the second largest percentage of outstanding shares, with 3.51% or 1.14 Million shares worth $2.08 Million as of ...

Article found on: marketingsentinel.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up